We are live on
!
Find out more
DAM
Doheny Asset Management Portfolio holdings
AUM
$153M
1-Year Est. Return
42.04%
This Fund
S&P 500
This Quarter
Est. Return
-2.05%
1 Year Est. Return
+42.04%
3 Year Est. Return
+121.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$190M
AUM Growth
-$24.1M
(-11%)
Cap. Flow
-$16.3M
Cap. Flow
% of AUM
-8.57%
Top 10 Holdings %
Top 10 Hldgs %
38.37%
Holding
113
New
5
Increased
14
Reduced
53
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Karyopharm Therapeutics
KPTI
|
+$3.04M |
| 2 |
AIMT
Aimmune Therapeutics
AIMT
|
+$2.91M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$2.26M |
| 4 |
Halozyme
HALO
|
+$1.07M |
| 5 |
Gilead Sciences
GILD
|
+$895K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energous
WATT
|
+$4.26M |
| 2 |
Wells Fargo
WFC
|
+$3.68M |
| 3 |
EXAS
Exact Sciences
EXAS
|
+$2.35M |
| 4 |
GLDD
Great Lakes Dredge & Dock
GLDD
|
+$1.8M |
| 5 |
SRLP
SPRAGUE RESOURCES LP
SRLP
|
+$1.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.24% |
| 2 | Healthcare | 15.3% |
| 3 | Financials | 12.79% |
| 4 | Energy | 12.07% |
| 5 | Real Estate | 11.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Forte Biosciences
FBRX
$1.57B
| $177K | 0.09% |
40
+9
| +29% | +$41.7K |
|
|
ACHN
102
DELISTED
Achillion Pharmaceuticals
ACHN
| $145K | 0.08% |
39,000
| – | – |
|
|
SRCI
103
DELISTED
SRC Energy Inc
SRCI
| $103K | 0.05% |
10,900
| – | – |
|
104
Advanced Micro Devices
AMD
$776B
| – | – |
-63,470
| Closed | -$652K |
|
105
Comcast
CMCSA
$85B
| – | – |
-5,200
| Closed | -$208K |
|
|
EXAS
106
DELISTED
Exact Sciences
EXAS
| – | – |
-44,640
| Closed | -$2.35M |
|
|
GLDD
107
DELISTED
Great Lakes Dredge & Dock
GLDD
| – | – |
-333,500
| Closed | -$1.8M |
|
108
Meta Platforms (Facebook)
META
$1.42T
| – | – |
-7,130
| Closed | -$1.26M |
|
109
Puma Biotechnology
PBYI
$404M
| – | – |
-8,800
| Closed | -$870K |
|
110
Wynn Resorts
WYNN
$10.3B
| – | – |
-2,335
| Closed | -$394K |
|
|
PE
111
DELISTED
PARSLEY ENERGY INC
PE
| – | – |
-11,300
| Closed | -$333K |
|
|
CMO
112
DELISTED
Capstead Mortgage Corp.
CMO
| – | – |
-34,400
| Closed | -$298K |
|
Similar funds
BVC
BCI
VFS
MDP
HPM
APW
CCA
SOWAS
Doheny Asset Management's Q1 2018 Portfolio in Review
As of Q1 2018, Doheny Asset Management held 113 positions worth $190M, down 11% from $215M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Doheny Asset Management withdrew a net $16.3M in Q1 2018, closing 10 positions and reducing 53 holdings. Its most notable exit was Exact Sciences, an estimated $2.35M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Doheny Asset Management opened a new position in Karyopharm Therapeutics worth $3.07M.
- Doheny Asset Management's largest Q1 2018 buy was Karyopharm Therapeutics: 15,266 shares worth $3.07M.
- Doheny Asset Management added most to Kyntra Bio in Q1 2018, an estimated $2.26M increase.
- Doheny Asset Management's biggest Q1 2018 reduction was Energous, cutting an estimated $4.26M.
- Doheny Asset Management fully exited Exact Sciences in Q1 2018, selling an estimated $2.35M.
- Doheny Asset Management's ten largest holdings make up 38% of its $190M portfolio in Q1 2018.
- Doheny Asset Management opened 5 new positions and closed 10 in Q1 2018.
- Doheny Asset Management's portfolio value fell 11% quarter-over-quarter to $190M.
Based on Doheny Asset Management's 13F filing for Q1 2018, filed 17 May 2018.